Skip to main content
An official website of the United States government

Michael Ortiz

A man, Dr. Michael Ortiz, with brown hair and brown eyes and wearing a grey suit with a red tie, smiles at the camera.

Outside of his clinical work and research, Dr. Michael Ortiz loves cooking, gardening, and spending time with his young daughter.

Credit: National Cancer Institute

Assistant Professor of Pediatrics, Memorial Sloan Kettering Cancer Center

In medical school, Dr. Michael Ortiz (he/him) decided to work with children after a mentoring program paired him with a boy who had Ewing sarcoma. “I connected with him,” Michael said. “And I was really motivated to help.”

Michael is a physician–scientist who cares for children with rare solid tumors, especially kidney and liver tumors. With his research, he works to bring the most promising treatments to the children who need them. But knowing which drugs work best for rare cancers is challenging because treatment data are sparse and not standardized.

“CCDI has the potential to be a game changer for us,” Michael said, adding that with data on rare cancers consolidated and standardized, he could use the data to build clinical trials for only the most effective treatments. “If we get engagement from the pediatric oncology community,” he said, “we can learn a tremendous amount from each other.”

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Michael Ortiz was originally published by the National Cancer Institute.”

Email